N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules. (Q39930416)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 October 2008

N-terminal region of α-synuclein is essential for the fatty acid-induced oligomerization of the molecules

Language	Label	Description	Also known as
English	N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules.	scientific article published on 9 October 2008	N-terminal region of α-synuclein is essential for the fatty acid-induced oligomerization of the molecules

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Hiroki Karube

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Masahiro Sakamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Shigeki Arawaka

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Susumu Hara

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Hiroyasu Sato

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Chang-Hong Ren

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Saori Goto

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Shingo Koyama

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Toru Kawanami

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Keiji Kurita

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Takeo Kato

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

9 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

582

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

25-26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

3693-3700

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18848547%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

alpha-Synuclein locus triplication causes Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

A broken alpha -helix in folded alpha -Synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.10.001

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39930416&oldid=1474612427"